Fed. Circ. Revives Patent Antitrust Claims Against Tyco
The Federal Circuit on Wednesday revived Mutual Pharmaceutical Company Inc.'s antitrust claims accusing Tyco Healthcare Group LP of filing a sham patent infringement suit and petition with federal drug regulators to...To view the full article, register now.
Already a subscriber? Click here to view full article